• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Here's Why Tilray Stock Is the Wild Child

Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
By STEPHEN GUILFOYLE
Nov 13, 2018 | 11:03 AM EST
Stocks quotes in this article: CGC, STZ, ACB, TLRY

Canopy Growth (CGC) has been called the best in class, as far as Canadian cannabis players are concerned. That firm, having benefited from the hefty investment made by U.S. alcoholic beverage maker Constellation Brands (STZ)  , will report on Wednesday morning. Aurora Cannabis (ACB) has been called the best risk averse option due to it's low market price, and that firm did report year over year revenue growth of 259%. Both of these names are locally domiciled at the New York Stock Exchange. There is another such name that enters nearly every cannabis-based conversation. That would be the Wild Child. That would be Tilray (TLRY) , listed over at the Nasdaq.

Sold The News

Cannabis stocks were for the most part, pretty darned hot over the two months leading into federal legalization across Canada for recreational use. The groups largely sold off after the fact. That was broadly expected as share prices had run ahead of reality, and that is also exactly how markets behaved in response to California's state level legalization way back toward the start of the year. The fact that stores that sell cannabis in Canada for recreational use have regularly, or it just seems like they have (I am not in Canada), run out of product. This leaves growers/producers in the position of prioritizing the medical use side of what they do.

Industry expectations for TLRY are for EPS of $-0.14. I have not heard anything in the way of a whisper number. Revenues are projected for the quarter at $10.1 million, but there is such a wide range of analyst expectations here, that I am hesitant to label anything as consensus. The lion's share of that revenue, safe to say, is expected to have been provided by the medical use segment.

Andrew Left

Perhaps the highest profile impact on Tilray equity performance, has been the interest of outspoken investor Andrew Left of Citron Research. Left has maintained a short position throughout that would appear dangerous to most, yet Left seems very confident. Not only does Left mention the probable entry of U.S. competitors into the space at some point over the next few years, while stressing increased downside risk as TLRY nears the IPO lock up expiration date. I think that item right there is a very real threat to this stock, one that might be significantly understated.

That date is not readily upon us, but it is out there stalking a shareholder near you as soon as January 15th. The stock you may recall was priced at $17 bucks a share.

The chart does not provide, at least not to me, a lot of guidance. We only know that volatility will likely increase as we move through winter. My instinct is to join Citron on the short side. Bear in mind however that almost 20% of the entire public float is held in short positions so this is a crowded trade. An investor would be out of his or her mind to short this one un-hedged. A January $115 TLRY call would cost the trader $18.70 this morning. For me, that makes this name a no-go.

The Something For Nothing Trade?

Bet you did not know that this morning you can sell one January 2020 (I kid you not) $50 put at $11.60. Just goes to show you that enough people think that price likely enough to overvalue (?) such a possibility. If you do get stuck buying these shares, (Better have $5 grand handy at the time) your net basis in 14 months would be 39.40. If not, that's $1,160 in your pocket. Holiday shopping money?

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Stephen Guilfoyle had no position in the securities mentioned.

TAGS: Investing

More from Investing

Nvidia Is Taking Fresh Steps to Boost its Sales to Gamers - Tech Check

Eric Jhonsa
Feb 22, 2019 8:51 PM EST

The GPU giant just launched a new mid-range product that has done well in reviews. And it might be prepping a new high-end offering.

The Game Remains the Same in This Stock Market: Keep Playing It

James "Rev Shark" DePorre
Feb 22, 2019 4:49 PM EST

The Nasdaq is now up nine weeks in a row, but what was most notable this week was the excellent stock-picking.

Chart of the Day: Kraft Heinz Credit Outlook Is Troubling

Kevin Curran
Feb 22, 2019 3:50 PM EST

KHC has a big problem on its balance sheet.

Infinera Looks to Have Formed a 'Bullish Reversal Pattern'

Guy Ortmann
Feb 22, 2019 3:10 PM EST

The price of INFN is spiking again today in response to positive quarterly earnings from the communications equipment maker.

Bullish Charts and a Quant 'Buy' Recommendation on Newmont Mining

Bruce Kamich
Feb 22, 2019 2:50 PM EST

Imagine how strong the charts might look if the U.S. dollar turned lower.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:42 PM EST KEVIN CURRAN

    Kraft Heinz Hits Numerous ETFs

    Even for those avoiding Kraft Heinz stock, contr...
  • 11:11 AM EST KEVIN CURRAN

    KHC Crashes Through Technical Floor, Options Action Accelerates

    The RSI on Kraft Heinz is reflecting a shockingl...
  • 11:48 AM EST BOB LANG

    Making a Case for Microsoft and Snap

    Mr Softy has long been a laggard and late to the p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login